Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Aevis Victoria S.A. (AEVS.SW)
CHF12.40
-0.70 (-5.34%)
CH SIX Healthcare Medical - Care Facilities
Address
Rue Georges-Jordil 4 1700
Fribourg, CH
Fribourg, CH
CEO
Fabrice Zumbrunnen
Website
aevis.com
IPO
2001-07-12
ISIN CH0478634105
Description
Aevis Victoria SA is a Swiss holding company with diversified interests spanning the healthcare, hospitality, lifestyle, and infrastructure sectors. Its operational structure is divided into key segments: Hospitals, Hospitality, Telemedicine, and Real Estate. The group manages an extensive portfolio, which includes 22 hospitals providing 1,496 beds, and oversees 941 rooms within its real estate holdings, representing a total rentable area of 188,109 square meters. Beyond its core hospital services, Aevis Victoria offers telemedicine, ambulance transport, and day clinic facilities. Its broad range of business ventures further encompasses patient hotels, "better aging" programs, radiology institutes, pharmacies, ophthalmology clinics, property management, stem cell applications, cosmetic services, and publishing, alongside organizing various seminars. The company's corporate headquarters are situated in Fribourg, Switzerland, and it operates as a subsidiary of M.R.S.I. Medical Research, Services and Investments S.A.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
CHF12.40
-0.70 (-5.34%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
7.3K
Beta
-0.09
Float Shares
9.93M
Free Float %
11.8%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | -4.41% | -4.76% | -2.99% | +0.00% | -1.89% | -3.70% | -28.96% | -3.35% | +46.73% | -86.73% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
12.40
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
1.59
Distress
Piotroski F-Score
5 / 9
Average
MOAT Score
0 / 10
No MOAT
Composite Rating
C-
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Care Facilities: +10.2%+12.1% ★ Q4'25: +37.3% (vs Q4'23)
-
EPS growth Medical - Care Facilities: +19.2%-603.8% Q4'25: +14.7% (vs Q4'23)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%-3.9% Q4'25: +5.5% (vs Q4'23)
-
EBIT margin Medical - Care Facilities: +11.3%-4.5% Q4'25: -9.6% (vs Q4'23)
-
ROIC Medical - Care Facilities: +6.8%-3.5% Q4'25: -14.5% (vs Q4'23)
-
Share dilution Medical - Care Facilities: +0.0%-1.1% ★ Q4'25: +0.1% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×38.13× Q4'25: -15.63× (vs Q4'23)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 1999 actual |
Dec 2001 actual |
Dec 2002 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
21.15M
est.
|
23.23M
est.
|
18.78M
est.
|
517.12M
est: 550.13M (-6.0%)
|
582.51M
est: 620.16M (-6.1%)
|
577.13M
est: 580.58M (-0.6%)
|
697.23M
est: 871.88M (-20.0%)
|
696.57M
est: 733.84M (-5.1%)
|
823.26M
est: 752.11M (+9.5%)
|
1.03B
est: 691.57M (+49.0%)
|
914.36M
est: 884.00M (+3.4%)
|
1.01B
est: 913.00M (+10.7%)
|
1.13B
est: 1.08B (+5.2%)
|
1.10B
1.10B – 1.10B
+1.9% YoY
|
1.13B
1.13B – 1.13B
+3.1% YoY
|
1.17B
1.17B – 1.17B
+3.1% YoY
|
| EBITDA |
1.78M
est.
|
1.92M
est.
|
1.55M
est.
|
74.07M
est: 45.36M (+63.3%)
|
84.71M
est: 51.14M (+65.6%)
|
80.07M
est: 47.87M (+67.3%)
|
236.93M
est: 71.89M (+229.6%)
|
34.48M
est: 60.51M (-43.0%)
|
83.47M
est: 62.02M (+34.6%)
|
128.30M
est: 151.89M (-15.5%)
|
49.06M
est: 74.36M (-34.0%)
|
92.49M
est: 71.77M (+28.9%)
|
24.91M
est: 84.62M (-70.6%)
|
86.24M
86.24M – 86.24M
+1.9% YoY
|
88.87M
88.87M – 88.87M
+3.1% YoY
|
91.62M
91.62M – 91.62M
+3.1% YoY
|
| EBIT |
284.0K
est.
|
305.8K
est.
|
247.1K
est.
|
28.73M
est: 7.24M (+296.8%)
|
34.21M
est: 8.16M (+319.1%)
|
24.74M
est: 7.64M (+223.8%)
|
177.09M
est: 11.48M (+1,443.2%)
|
-21.27M
est: 9.66M (-320.3%)
|
21.79M
est: 9.90M (+120.2%)
|
61.71M
est: 144.21M (-57.2%)
|
-12.88M
est: 11.87M (-208.5%)
|
25.67M
est: 9.60M (+167.3%)
|
-51.09M
est: 11.32M (-551.4%)
|
11.53M
11.53M – 11.53M
+1.9% YoY
|
11.89M
11.89M – 11.89M
+3.1% YoY
|
12.25M
12.25M – 12.25M
+3.1% YoY
|
| Net Income |
25.62M
est.
|
1.98M
est.
|
18.05M
est.
|
2.31M
est: 13.74M (-83.2%)
|
-922.0K
est: 27.51M (-103.4%)
|
-8.66M
est: -6.58M (-31.7%)
|
163.20M
est: 241.37M (-32.4%)
|
-31.80M
est: 29.41M (-208.1%)
|
-4.27M
est: 34.61M (-112.3%)
|
58.81M
est: 131.39M (-55.2%)
|
-39.30M
est: 122.82M (-132.0%)
|
-2.87M
est: 2.53M (-213.6%)
|
-20.11M
est: 10.35M (-294.2%)
|
13.49M
13.49M – 13.49M
+30.3% YoY
|
29.08M
29.08M – 29.08M
+115.6% YoY
|
36.67M
36.67M – 36.67M
+26.1% YoY
|
| SGA |
1.09M
est.
|
1.18M
est.
|
950.3K
est.
|
30.51M
est: 27.84M (+9.6%)
|
36.25M
est: 31.39M (+15.5%)
|
41.77M
est: 29.38M (+42.2%)
|
43.95M
est: 482.89M (-90.9%)
|
42.21M
est: 37.14M (+13.6%)
|
44.66M
est: 38.06M (+17.3%)
|
49.80M
est: 328.07M (-84.8%)
|
43.47M
est: 45.64M (-4.8%)
|
47.93M
est: 45.01M (+6.5%)
|
55.45M
est: 53.06M (+4.5%)
|
54.08M
54.08M – 54.08M
+1.9% YoY
|
55.73M
55.73M – 55.73M
+3.1% YoY
|
57.46M
57.46M – 57.46M
+3.1% YoY
|
| EPS |
0.30
est.
|
0.19
est.
|
0.21
est.
|
0.03
est: 0.16 (-80.8%)
|
-0.01
est: 0.32 (-103.7%)
|
-0.11
est: -0.08 (-41.9%)
|
2.09
est: 2.85 (-26.6%)
|
-0.40
est: 0.35 (-215.3%)
|
-0.05
est: 0.41 (-112.5%)
|
0.70
est: 0.26 (+169.6%)
|
-0.47
|
-0.03
est: 0.03 (-213.7%)
|
-0.24
est: 0.12 (-295.4%)
|
0.16
0.16 – 0.16
+30.3% YoY
|
0.35
0.35 – 0.35
+115.6% YoY
|
0.44
0.44 – 0.44
+26.1% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-28 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-27 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-26 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-22 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-21 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-19 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-18 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-15 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-13 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-12 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-11 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-08 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-07 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-06 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-05 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-04 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-30 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-29 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-28 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-27 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-24 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-23 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-22 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-21 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-17 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-16 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
169.10M
OE per share TTM
2.01
Owner's Yield
15.41%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
120.0%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 4 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares Core SPI(R) ETF (CH) CHSPI.SW | 0.02% | 1.08M | 0.10% |
| 2 | Dimensional - International Core Equity 2 ETF DFIC | 0.00% | 34.6K | 0.22% |
| 3 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 12.2K | 0.28% |
| 4 | Dimensional - International Small Cap ETF DFIS | 0.00% | 564.14 | 0.39% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
-10.8K
Shares Outstanding
84.42M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Antoine Hubert | Executive Chairman | 1M | male |
| Andri Färber | Chief Executive Officer of AD Swiss Net AG | — | male |
| Anna Grabner | Chief Executive Officer of Genolier Innovation Hub | — | female |
| Dino Cauzza | Chief Executive Officer of Swiss Medical Network | — | male |
| Eric Frey | Chief Executive Officer of Infracore | — | male |
| Fabrice Zumbrunnen | Chief Executive Officer | — | male |
| Mario Bernasconi | Chief Executive Officer of Well Gesundheit AG | — | male |
| Michel Keusch | Chief Financial Officer & Chief Investment Officer | — | male |
| Andreas Schollin-Borg | Chief Executive Officer of Batgroup | — | male |
| Séverine Van der Schueren | Chief Administrative Officer | — | female |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for AEVS.SW
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
